Sleep Researchers Defend Push to Classify Central Hypopneas as New Therapies Emerge
In a Journal of Clinical Sleep Medicine reply, researchers Ahn and Malhotra concede that central hypopnea classification lacks validated thresholds ...
In a Journal of Clinical Sleep Medicine reply, researchers Ahn and Malhotra concede that central hypopnea classification lacks validated thresholds ...
A new Translational Psychiatry review argues that integrating endocannabinoid neurobiology, genetic risk loci, and early-phase drug trials could finally enable ...
Video analysis of 29 NHS memory clinic consultations shows doctors inconsistently frame the benefits and side effects of dementia medications, ...
As powerful new weight-loss drugs transform obesity treatment, leading surgeons argue that metabolic bariatric surgery remains an essential, durable component ...
Researchers in China have developed MKMed, a cross-modal AI framework that aligns five types of drug knowledge to overcome the ...
A letter in European Geriatric Medicine argues that disputes over the STOPP/START criteria expose the need for transparent evidence-grading standards ...
A new review argues that Brixadi, an extended-release injectable buprenorphine approved for opioid use disorder, warrants clinical investigation as a ...
A nationwide Finnish register study of 282,307 adults examines how sociodemographic and socioeconomic factors shape who uses anti-obesity medications.
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine